C-peptide-stimulated nitric oxide production in a cultured pulmonary artery endothelium is erythrocyte mediated and requires Zn2+

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 1, 2013, Pages 44-52

  Giebink, Adam W ^a   Vogel, Paul A ^a   Medawala, Wathsala ^a   Spence, Dana M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

ATP; C peptide; Calcium ionophore; ENOS; Microfluidics; Pulmonary artery; Zn2+

Indexed keywords

ADENOSINE TRIPHOSPHATE; C PEPTIDE; CALCIUM; CALCIUM IONOPHORE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCENT DYE; PURINERGIC RECEPTOR; ZINC;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; ERYTHROCYTE; HEMODYNAMICS; MICROFLUIDICS; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; C-PEPTIDE; CALCIMYCIN; CALCIUM; CALCIUM IONOPHORES; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; HUMANS; NITRIC OXIDE; PULMONARY ARTERY; ZINC;

EID: 84872224813     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2359     Document Type: Article

References (46)

1. Steiner DF, Clark JL, Nolan C, et al. Proinsulin and the biosynthesis of insulin. Recent Prog Horm Res 1969; 25: 207-282.
2. Rubenstein AH, Block MB, Starr J, Melani F, Steiner DF. Proinsulin and C-peptide in blood. Diabetes 1972; 21(2 Suppl): 661-672.
3. Hoogwerf BJ, Bantle JP, Gaenslen HE, et al. Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 1986; 35(2): 122-125.
4. Jensen ME, Messina EJ. C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am J Physiol 1999; 276(4 Pt 2): H1223-H1228.
5. Scalia R, Coyle KM, Levine BJ, Booth G, Lefer AM. C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J 2000; 14(14): 2357-2364.
6. Young LH, Ikeda Y, Scalia R, Lefer AM. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2000; 279(4): H1453-H1459.
7. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 1987; 327(6122): 524-526.
8. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 170(2): 843-850.
9. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 1983; 52(3): 352-357.
10. Wallerath T, Kunt T, Forst T, et al. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 2003; 9(2): 95-102.
11. Kitamura T, Kimura K, Makondo K, et al. Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 2003; 46(12): 1698-1705.
12. Sprague RS, Olearczyk JJ, Spence DM, Stephenson AH, Sprung RW, Lonigro AJ. Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol 2003; 285(2): H693-H700.
13. Meyer JA, Froelich JM, Reid GE, Karunarathne WK, Spence DM. Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia 2008; 51(1): 175-182.
14. Oblak TDA, Root P, Spence DM. Fluorescence monitoring of ATP-stimulated, endothelium-derived nitric oxide production in channels of a poly(dimethylsiloxane)-based microfluidic device. Anal Chem 2006; 78(9): 3193-3197.
15. McDonald JC, Duffy DC, Anderson JR, et al. Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 2000; 21(1): 27-40.
16. Genes LI, Tolan NV, Hulvey MK, Martin RS, Spence DM. Addressing a vascular endothelium array with blood components using underlying microfluidic channels. Lab Chip 2007; 7(10): 1256-1259.
17. Letourneau S, Hernandez L, Faris AN, Spence DM. Evaluating the effects of estradiol on endothelial nitric oxide stimulated by erythrocyte-derived ATP using a microfluidic approach. Anal Bioanal Chem 2010; 397(8): 3369-3375.
18. Letourneau S, Hernandez L, Faris AN, Spence DM. Evaluating the effects of estradiol on endothelial nitric oxide stimulated by erythrocyte-derived ATP using a microfluidic approach. Anal Bioanal Chem 2010; 397(8): 3369-3375.
19. Vogel PA, Halpin ST, Martin RS, Spence DM. Microfluidic transendothelial electrical resistance measurement device that enables blood flow and postgrowth experiments. Anal Chem 2011; 83(11): 4296-4301.
20. Li L, Oshida Y, Kusunoki M, et al. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia 1999; 42(8): 958-964.
21. Joshua IG, Zhang Q, Falcone JC, Bratcher AP, Rodriguez WE, Tyagi SC. Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide. J Cell Biochem 2005; 96(6): 1149-1156.
22. Stevens MJ, Zhang W, Li F, Sima AA. C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol Endocrinol Metab 2004; 287(3): E497-E505.
23. Cotter MA, Ekberg K, Wahren J, Cameron NE. Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition. Diabetes 2003; 52(7): 1812-1817.
24. Stevens MJ, Dananberg J, Feldman EL, et al. The linked roles of nitric oxide, aldose reductase and, (Na+, K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 1994; 94(2): 853-859.
25. Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 2003; 26(3): 832-836.
26. Delaney C, Shaw J, Day T. Acute, local effects of iontophoresed insulin and C-peptide on cutaneous microvascular function in type 1 diabetes mellitus. Diabet Med 2004; 21(5): 428-433.
27. Kitamura T, Kimura K, Jung BD, et al. Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 2002; 366(Pt 3): 737-744.
28. Forst T, De La Tour DD, Kunt T, et al. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+, K+-ATPase activity in diabetes mellitus type I. Clin Sci (Lond) 2000; 98(3): 283-290.
29. Forst T, Kunt T, Pohlmann T, et al. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest 1998; 101(10): 2036-2041.
30. Chataigneau T, Feletou M, Huang PL, Fishman MC, Duhault J, Vanhoutte PM. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 1999; 126(1): 219-226.
31. Osanai T, Fujita N, Fujiwara N, et al. Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol Heart Circ Physiol 2000; 278(1): H233-H238.
32. Meyer JA, Subasinghe W, Sima AA, et al. Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin. Mol Biosyst 2009; 5(10): 1157-1162.
33. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol 1996; 271(6 Pt 2): H2717-H2722.
34. van der Meer AD, Poot AA, Duits MH, Feijen J, Vermes I. Microfluidic technology in vascular research. J Biomed Biotechnol 2009; 2009: 823148.
35. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001; 60(4): 1258-1265.
36. Maezawa Y, Yokote K, Sonezaki K, et al. Influence of C-peptide on early glomerular changes in diabetic mice. Diabetes Metab Res Rev 2006; 22(4): 313-322.
37. Kamikawa A, Ishii T, Shimada K, et al. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab Res Rev 2008; 24(4): 331-338.
38. Ohtomo Y, Bergman T, Johansson BL, Jornvall H, Wahren J. Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 1998; 41(3): 287-291.
39. Graciano ML, Nishiyama A, Jackson K, et al. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol 2008; 294(1): F161-F169.
40. Ekberg K, Brismar T, Johansson BL, et al. C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care 2007; 30(1): 71-76.
41. Karunarathne W, Ku CJ, Spence DM. The dual nature of extracellular ATP as a concentration-dependent platelet P2X1 agonist and antagonist. Integr Biol (Camb) 2009; 1(11-12): 655-663.
42. Anderson KB, Karunarathne W, Spence DM. Measuring P2X1 receptor activity in washed platelets in the absence of exogenous apyrase. Anal Methods-Uk 2012; 4(1): 101-105.
43. Ku CJ, D'Amico Oblak T, Spence DM. Interactions between multiple cell types in parallel microfluidic channels: monitoring platelet adhesion to an endothelium in the presence of an anti-adhesion drug. Anal Chem 2008; 80(19): 7543-7548.
44. Hutton JC. The insulin secretory granule. Diabetologia 1989; 32(5): 271-281.
45. Medawala W, McCahill P, Giebink A, Meyer J, Ku CJ, Spence DM. A molecular level understanding of zinc activation of C-peptide and its effects on cellular communication in the bloodstream. Rev Diabet Stud 2009; 6(3): 148-158.
46. Shafqat J, Melles E, Sigmundsson K, et al. Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell Mol Life Sci 2006; 63(15): 1805-1811.